Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-0974-2016

Drug recall · June 15, 2016

CEFTRIAXONE for Injection USP recall

Why: CGMP Deviations: Out of specification (OOS) intermediate in the subsequent processes to manufacture the final API.

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

CEFTRIAXONE for Injection USP, 250mg/vial, Rx only, MFG: LUPIN LIMITED INDIA, Packaged by Aidarex Pharmaceuticals, NDC 53217-0117-01

Lots / codes

Lot#: 47312-1, Exp 01/2018

Quantity
10
Company
Aidarex Pharmaceuticals LLC, Corona, CA
Distribution
IN, GA
Initiated
June 1, 2016 · Voluntary: Firm initiated
Classified
June 7, 2016
Reported
June 15, 2016
Ended
October 14, 2016
How notified
FAX

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Ceftriaxone

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.